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ABSTRACT OF THESIS 
INFLAMMATION AND APOPTOSIS WITHIN THE COLON FROM HORSES WITH 
BLACK WALNUT EXTRACT-INDUCED LAMINITIS - PROGNOSTIC FACTORS 
AFTER ESOPHAGEAL OBSTRUCTION IN HORSES 
 
Laminitis has been defined as a progressive disease in which digital pain may be 
caused by laminar inflammation or destruction, or may be caused by pressure either from 
the displacement of the third phalanx into the sole, or laminar pressure secondary to 
edema, or a combination of these.  Numerous studies have been conducted in the last 
twenty years on the vascular, mechanical and biochemical events occurring in the equine 
foot, yet the pathogenesis of this life-threatening disease still is unclear.  Due to the 
multifactorial origin of laminitis and the lack of consistency in its manifestation in nature, 
understanding the pathogenesis depends mostly on reliable experimental models, such as 
carbohydrate overload and black walnut extract (BWE) toxicosis.  
The link between black walnut toxicosis and the mechanism initiating laminitis is 
not completely understood. One study demonstrated that at the onset of laminitis, horses 
treated with BWE developed eosinophilic colitis, edema, and hemorrhage associated with 
concomitant reduction of intestinal transmucosal resistance in all segments of colon ex 
vivo. These findings support the hypothesis that the gastrointestinal tract may be the 
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first focus of a systemic inflammatory response and that the disruption of the mucosal 
barrier may allow the release of intestinal toxins and vasoactive amines into the systemic 
circulation which results in triggering the development of laminitis.  However, the 
cellular processes and events leading to colonic mucosal impairment during the 
prodromic phase of BWE-induced laminitis need further investigation.   
The objective of the present study was to investigate calprotectin expression, 
epithelial and endothelial apoptosis and their correlation in the colon of horses 
undergoing BWE toxicosis. 
We used paraffin blocks of full sections of colon from 19 horses: 6 horses at the 
developmental time-point of leukopenia (DTP), 6 at the onset of Obel grade 1 laminitis 
(LAM) after BWE-administration, and 7 controls. 
Specimens were stained with H&E for histopathologic examination. In addition, 
tissues underwent immunohistochemical evaluation of calprotectin expression with MAC 
387 antibody and epithelial and endothelial apoptosis with caspase-3 active antibody. 
Differences in calprotectin scoring and percentage of apoptotic cells were statistically 
analyzed.  Correlation between calprotectin expression and apoptosis was evaluated.  
Histologically, tissues from BWE-treated horses showed increased eosinophil and 
lymphocyte epitheliotropism, superficial inflammatory cell karyorrhexis and neutrophilic 
infiltration (LAM group).  The DTP group had a higher (p<0.01) calprotectin score 
compared to the control group, while there was no significant difference in percentage of 
epithelial and endothelial apoptotic cells between groups (p=0.08, p=0.48), nor was there 
a significant correlation between calprotectin score and epithelial or endothelial apoptosis 
(p=0.69 and p=0.29 respectively). 
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There is preliminary evidence that exposure of horses to BWE results in an early 
inflammatory response in the colon, which may contribute to compromise the intestinal 
barrier.  No differences in epithelial and endothelial apoptosis were observed between 
groups.  Different mechanisms, such as disruption of intercellular junctions in non-
apoptotic cells may result in increased intestinal permeability and should be further 
investigated. 
* * * 
Esophageal obstruction or “choke” is a common clinical disorder and the most 
common esophageal affliction in the horse.  It can be a primary disorder or secondary to 
pre-existing pathologic conditions, such as squamous cell carcinoma, cysts within the 
esophageal wall, para-esophageal abscesses, strictures, diverticula, esophageal motility 
disorders, neurologic and neuromuscular abnormalities, guttural pouch mycosis, 
pharyngeal trauma, botulism and grass sickness.  Complications after an episode of 
esophageal obstruction are common and may include aspiration pneumonia, pleuritis, 
mucosal esophageal ulceration and stricture formation, esophageal perforation, chronic 
recurrent obstruction, postoperative infection, laminitis, laryngeal paralysis and Horner‟s 
syndrome.  
Previous studies have described clinical findings in horses with esophageal 
obstruction, but there are no reports that attempt to make correlations of clinical findings 
with outcome. The objective of our study was to find specific clinical features of horses 




The clinical records of 109 horses admitted with esophageal obstruction between 
April 1992 and February 2009 for esophageal obstruction were reviewed.  Variables 
included breed, sex, age, temperature, heart rate and respiratory rate at admission, 
whether or not thoracic or esophageal radiographs were performed, and radiographic 
findings.  When endoscopy was performed, tracheal contamination with food material 
was subjectively graded as “absent” when no visible particles were detected, “mild” 
when there were single food particles visualized in the trachea, “moderate” when small 
amounts of aspirated fluid were detected on the tracheal floor, or “severe” when large 
amounts of aspirated fluid were detected on the tracheal floor and/or food particles were 
present diffusely within the trachea.  Visible esophageal lesions were classified as 
absence of irritation or swelling, mild to moderate mucosal lesions, or severe ulceration 
or morphological abnormalities.  The location of the obstruction was classified as 
proximal, middle or distal one-third of the esophagus as determined endoscopically.  
Hematologic and biochemical variables at the time of admission included packed cell 
volume (PCV), total protein (TP), blood glucose, bicarbonate, and anion gap.  Recorded 
treatments included whether antibiotics were administered and the route of 
administration, whether non-steroidal anti-inflammatory drugs (NSAIDs), alpha-2 
agonists, opioids, acepromazine and oxytocin were used, and whether general anesthesia 
was required to resolve the obstruction.  The duration of the esophageal obstruction prior 
to admission (less than 3 hours, 3 to 6.3 hours, 6.4 to 12.3 hours, 12.4 to 48 hours or 
greater than 48 hours), and the time between admission and resolution of the obstruction 
(relieved spontaneously at the time of admission, during initial treatment, within 24 
hours, greater than 24 hours, or never resolved) were recorded.  The association between 
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clinical, hematological, biochemical, and therapeutic variables with the likelihood of 
developing complications was investigated by a univariable logistic regression model, 
followed by multivariable analysis. 
Age less than one year or greater than 15 years, radiographic evidence of 
pulmonary disease, grade of esophageal lesion, TP > 70 g/L, the use of both oral and 
parenteral antibiotics, the use of general anesthesia, and duration of obstruction longer 
than 48 hours prior to admission were significantly associated with increased likelihood 
of complications via univariable analysis.  Since aspiration pneumonia alone represented 
almost 70% of the complications, its association with each variable of interest was further 
investigated.  In addition to age, total protein and the use of general anesthesia, intact 
male, respiratory rate at admission greater than 22 breaths per minute, and moderate to 
severe tracheal contamination were significantly associated with the likelihood of 
aspiration pneumonia via univariable analysis.  Multivariable logistic regression analysis 
revealed a significant association between intact males, age greater than 15 years, and the 
use of general anesthesia with the likelihood of developing complications.  This study 
gives insight into the understanding of factors that may affect prognosis in horses with 
esophageal obstruction and could give rise to a prospective study in the future. 
 
Ludovica Chiavaccini 
Department of Clinical Sciences 
Colorado State University 
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INFLAMMATION AND APOPTOSIS WITHIN THE COLON FROM 







 Chapter 1: Literature review on laminitis, calprotectin expression and apoptosis in 
the equine gastrointestinal tract  
 
General Overview on Equine Laminitis with Emphasis on its Pathogenesis 
Laminitis has been defined as a progressive disease, in which digital pain may be 
caused by laminar inflammation or destruction, or may be due to pressure either from the 
displacement of the third phalanx into the sole or laminar pressure secondary to edema, 
or a combination of these 
1
.  Despite numerous studies on the vascular, mechanical and 
biochemical events occurring in the equine foot, the pathogenesis of this life-threatening 
disease still is unclear 
2,3
. In general, two primary clinical forms of laminitis are 
recognized: mechanical and inflammatory.  
Mechanical laminitis is caused by weight bearing on the supportive forelimb or 
hind limb, when the contralateral is severely injured, or may occur as a bilateral forelimb 
disease in horses trained on excessively hard surfaces. The hemorrhagic nature of this 
laminitis suggests that its pathophysiology resides in the tearing and shearing forces 
transmitted through the bony column to the third phalanx and ultimately to the dermal-
epidermal laminar interface, more than in the compression of the solar vessels or 
circumflex arteries of the distal aspect of P3 (Fig. 1.1) 
1
.      
Inflammatory laminitis is often secondary to septic disease such as gastro-intestinal tract 
disorders (e.g. infectious enterocolitis, enteritis secondary to carbohydrate ingestion or 
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microflora deregulation), pleuropneumonia, retained placenta or acute metritis, 
endotoxemia or sepsis from any cause 
4,5
. Even though the pathogenesis of sepsis-related 
laminitis remains unclear, there is convincing evidence coming from experimental 
models (such as oligofructose or black walnut extract models) for systemic inflammation 
as the main etiopathological event 
3,6
. The changes observed in the laminae seem to be a 
local response to  systemic inflammation and share many similarities with the changes 
observed during multiple organ dysfunction syndrome (MODS) in human sepsis 
7,8
. The 
septic horse often exhibits clinical signs similar to the systemic inflammatory response 
syndrome (SIRS), a precursor of MODS in humans, such as fever, tachycardia and 
injected mucous membranes. Second, a systemic activation of the endothelium followed 
by activation of leukocytes, leads to migration of the latter from the blood stream into the 
perivascular tissue of the laminae and other organs, as it occurs in human organs 
8-10
. As 
extensively described later in this chapter, the local inflammation, culminating in 
production and release of reactive oxygen species (ROS) by the neutrophil population, 
may interfere with cytoskeleton dynamics and trigger the dysadhesion between epidermal 
and dermal lamellae (Fig. 1.1)  
11
. Previous studies suggested that one of the main events 
leading to the disruption of lamellar bonds is the breakdown of type IV and type V 
collagen and the protein laminin 5, by the activated gelatinases MMP-2 and MMP-9 
12-14
. 
Laminin attaches on one side to the collagen in basal lamina, on the other to the 
transmembrane protein α64 integrin, which, through the protein plectin, is linked to 
keratin intermediate filaments in the cell. This guarantees the connection between the 
epithelial cell and the basal lamina 
15
. MMP-2 is constitutively expressed by several cells, 
such as keratinocytes and seems to be part of the normal extracellular matrix turnover. Its 
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expression is normally down-regulated by the tissue inhibitor of metalloproteinase 
(TIMP) and alpha2-macroglobulin 
12,13
. In contrast, MMP-9 is often transiently 
expressed, except in neutrophils, which store the enzyme in granules and liberate it under 
various stimuli 
14,16
.  MMP-2 and MMP-9 are released as zymogens and then activated 
through the cleavage of the regulatory N-terminus. Even though the trigger factors of 
MMPs activation remain unclear, possible causes are ischemia, inflammation, oxidative 
stress 
12
, and, for MMP-2, the membrane-type MMP1 (MT1-MMP), which is 
proteolytically activated by the protein convertase PACE4 
14
. Once the bonds between 
the epidermal and dermal lamellae have been disrupted, the tearing and shearing forces 
due to weight bearing induce the rotation or the displacement of the third phalanx into the 
sole, or both, depending on the localization and extension of the dysadhesion 
7
. These 
observations together suggest that laminitis may be the final result of both the local 
response of systemic inflammation and imbalance between activation and inhibition of 
the normal laminar healing processes in the foot 
7,12,14
. As in human sepsis, not only 
endotoxins, but multiple types of toxins, such as gram-positive and gram-negative 
bacterial toxins, fungal toxins and viral components  are absorbed systemically and may 
induce a downstream inflammatory reaction leading to organ failure 
7
.  
Although there are similarities between the pathogenesis of human multiple organ 
failure and laminitis, the structural and physiological peculiarities of laminae make the 
foot the “target organ” in the horse, unlike other sepsis models in which  lungs, kidney 
and liver are usually primarily affected 
7
. First, the more severe inflammatory reaction in 
the laminae (as suggested by a higher cytokine expression with respect to other tissue) or 
the innate lack of superoxide dismutase (SOD), or both,  may result in insufficient 
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antioxidant capacity for dealing with the ROS produced by leukocytes infiltrating during 
the prodromic phase of systemic inflammation 
8,11,17,18
. Second, in contrast to lungs, 
kidney and liver, the laminae seem to lack a regional monocyte population. This may 
affect the regional inflammatory response and in the end the activation of MMPs 
1
. Third, 
the foot is subjected to distracting forces due to weight bearing and this makes it more 
susceptible to the disruption of connections between epidermal cells and basal lamina 
1,12
. 
In addition, the specific vascular anatomic features in this region, such as high interstitial 
pressure increasing with weight bearing, high capillary pressure, and opening of vascular 




Under the umbrella of inflammatory laminitis we may also include equine 
metabolic syndrome-associated laminitis and pasture-associated laminitis. The term 
metabolic syndrome was first proposed by Johnson (2002) for indicating obese horses at 
risk of laminitis. Later Treiber et al. introduced the term prelaminitic metabolic syndrome 
(PLMS) to specifically address those ponies at higher risk of pasture-associated laminitis, 
indicating that pasture-associated laminitis can be considered a “subtype” of metabolic 
syndrome-associated laminitis 
19,20
. The pathogenesis of metabolic syndrome and its 
relationship with increased susceptibility to laminitis is only partially understood 
19
. 
Presently two interrelated mechanisms have been suggested. First, obesity has been 
associated with low grade chronic inflammation 
20,21
. Adipose tissue, including 
adipocytes and macrophages, once considered only a storage tissue, has been recognized 
as the largest endocrine organ of the body, which can produce a large array of adipokines 
such as leptin, resistin, TNFα and TNFp, interferon- and a variety of interleukins as 
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IL1, IL6, IL8, IL10, monocyte chemotactin protein-1 and complement proteins 
21-23
. 
This chronic inflammatory status per se can increase the risk of a systemic inflammatory 
response and consequently all the local vascular and inflammatory changes described 
above leading to laminitis. Second, obesity and chronic inflammation have been 
demonstrated to be almost always associated with increase insulin resistance (IR) 
21,24,25
. 
Insensitivity to insulin results in hyperinsulinemia, hyperglycemia, and mobilization of 
fatty acids from the liver (hypertriglyceridemia). Free fatty acids appear to activate toll-
like receptor 4 and to aggravate the subclinical inflammatory condition 
22
. In addition, IR 
seems to lead to a vascular impairment in the laminae due to a deregulation between 
vasodilation and vasoconstriction. In fact, insulin receptors in the laminae activate both 
vasodilation through the synthesis of nitric oxide (NO) via the phosphatidylinositol 3-
phosphate (PIP3) pathway and vasoconstriction through the release of endothelin-1 (ET-
1) via the MAPK pathway. For causes that remain unclear, during insulin resistance, the 
PIP3 pathway is blocked, while the MAPK pathway remains active, leading to 
vasoconstriction, platelet activation and leukocyte adhesion and extravasation 
19,20,25-27
. In 
agreement with these findings, the concentration of immunoreactive ET-1 is increased in 
the connective tissue of the foot of horses with laminitis 
26,28
. Moreover, it has been 
recognized that the adipose tissue itself is one of the major sources of angiotensinogen 
and that it can locally regulate the conversion to angiotensin II, which may contribute to 
the vascular deregulation 
22
. IR seems also to directly activate the production of MMP2 
and MMP9 within the laminar tissue 
27
. In conclusion obesity creates a state of chronic 
inflammation, hyperinsulinemia and IR, leading to vascular impairment and initiating the 
cascade of events that converges into laminitis.   
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Pasture-associated laminitis alone embodies more than 50% of all cases of 
laminitis and can be summarized as a combination of genetic, dietetic factors and obesity 
19,20,29
. Certain horses and ponies seem to be more affected than others, even when kept in 
the same environment, and predisposed animals tend to have recurrent laminitis episodes. 
In general pony breeds seem to be more inclined to develop pasture-laminitis than horses 
due to inherent lower insulin sensitivity 
19
. In an inbred population of Welsh and 
Dartmoor ponies, a PLMS phenotype seemed to have a dominant mode of inheritance, 
suggesting a genetic predisposition to laminitis in these breeds. There are few studies 
addressing the same type of association in horses, but Morgans, Paso Finos, Arabians and 
Norwegian Fjords seem to have a higher predisposition to EMS. This fact may be an 
adaptive response in those native breeds coming from poor nutritional environments 
19
. In 
another study conducted by Bailey et al. (2008) in a mixed-breed population of ponies in 
the United Kingdom, laminitis-prone animals showed the prelaminitic phenotype only 
during the summer, suggesting that the summer pasture may exacerbate the hypertension, 
IR, hyperinsulinemia and hypertriglyceremia in predisposed animals. The content in non 
structural carbohydrates (NSCs) such as fructans, starch and simple sugar tends to 
increase during spring, is intermediate during fall and low in winter and at the end of the 
summer, with variations between different forages. Moreover NSCs tend to increase 
during the morning, reaching the maximal peak in the afternoon, and lowering again 
during the night. These sugars are easily absorbable in the gastrointestinal tract and 
rapidly increase the glycemia, with consequential exacerbation of IR and 
hyperinsulinemia in predisposed animals, triggering the laminitic episode 
19
. The second 
possible mechanism is extrapolated from the carbohydrate overload model in which 
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laminitis is experimentally induced administering a large amount of starch or 
oligofructose (OF) as a single bolus. The procedure will be explained in more detail later 
in this chapter. However it has been demonstrated that ingestion of a large quantity of 
rapidly fermentable carbohydrates into the cecum and the colon causes disequilibrium of 
the intestinal microflora, with proliferation of lactic-acid producing Streptococcus spp. 
and Lactobacillus spp. and subsequent lowering of the intraluminal pH and increasing 
intestinal permeability 
19,30
. These modifications result in production and absorption of 
endotoxins, exotoxins and vasoactive amines (in particular tryptamine, tyramine and 
phenylethylamine) by the hindgut environment, and may lead to the onset of laminitis 
19,30-33
. In some periods of the year, the quantity of NSCs ingested daily by grazing horses 
may approach experimental doses 
34
. It is also possible that lower doses of NSCs are 
sufficient to induce laminitis in predisposed animals, due to impaired intestinal barrier 
function, reduced detoxifying capacity of the liver, or higher sensitivity of the vasculature 
or the lamellar tissue to trigger factors 
19,20,30,32
. Finally, most ponies and horses kept on 
pasture tend to be obese 
1
. The association between obesity and laminitis has been 
previously discussed.  
Although the cascade of events triggering laminitis may differ, it has been 
suggested that, in the end, lamellar disruption is secondary to dysoxia of the foot 
1,35
. 
Several studies demonstrated that in the prodromal phase of laminitis there is an 
alternation of hypoperfusion and hyperperfusion of the foot leading to vascular 
impairment 
26,36,37
. Studies on the Starling‟s forces within the equine laminar vasculature, 
in both carbohydrate overload and black walnut extract models, demonstrated an early 
venocostriction, followed by increased capillary pressure, extravasation of fluids and 
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consequent edema of the digital interstitium 
35,37,38
. These findings are corroborated by 
the fact that laminar veins have been demonstrated more sensitive than arteries to ET-1, 
serotonin (5-HT), catecholamines, prostaglandins and hindgut-originated vasoactive 
monoamines in vitro 
28,33,39
, and administration of an ET-1 antagonist significantly 
reduces the post-capillary resistance in an isolated foot after carbohydrate overload-
induced laminitis 
35,37
.  The role of these molecules during the development of laminitis 
has been described earlier and will be discussed later in this chapter.  
 
Experimental Models for Inducing Equine laminitis 
Due to the multifactorial origin of laminitis and the lack of consistency in its 
manifestation in nature, understanding its pathogenesis depends mostly on reliable 
experimental models. There are currently two main models for inducing laminitis of 
alimentary origin: carbohydrate overload and black walnut extract toxicosis.  
1. Carbohydrate overload: The carbohydrate overload model draws from the 
observation that accidental access to grain starch induces laminitis in the horse 
40
. The original protocol consisted of the administration of 17.5 g/kg of wheat 
flour in 8L of tap water through a nasogastric tube 
41
. Due to the variable 
results and the high mortality of this model, the protocol was substituted with 
the administration of 10 g/Kg of commercial OF (Raftilose P95
a
) in 4L of water 
40
. In a recent study, Kalck et al. (2009) obtained the same 
effect with 5 and 7.5 g/Kg respectively. Both starch and OF are polymers of 
glucose, the first constituted by a chain of glucose molecules, the second by 
                                                          
a
 Orafti Active Food Ingredients, Tienen, Belgium 
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one molecule of glucose linked to one or more molecules of fructose, and both 
are highly fermentable in equine cecum and colon 
40
. The starch and OF 
overload models produce similar clinical and metabolic effects. The onset of 
laminitis is observed between 20-44 hours and 24-26 hours post ingestion 
respectively. This is accompanied by profuse diarrhea with electrolyte loss, 
dehydration, hypovolemic shock and endotoxemia 
40-43
. As previously 
anticipated, feeding high quantities of starch or OF induces a shift in the 
hindgut bacterial population 
44
. The predominant OF fermenting bacteria 
isolated as early as 2H post-administration (POA) is the equine hindgut 
streptococcal species (EHSS) Streptococcus lutetiensis, a member of the S. 
bovis/equinus complex. The shifts of Lactobacillus and E. coli subpopulations 
seem to occur secondarily and later in time with respect to the EHSS shift 
29
. 
Consequentially, S. lutetiensis seems to be the main bacteria responsible for 
the lowering of intraluminal pH, accompanied by increasing intestinal 
permeability, resorption of bacterial toxins and lactic acidemia 
29,40
. A recent 
study demonstrated that a massive EHSS death and cell lysis is observed 
around 16H POA, and the consequential release and absorption of bacterial 
components may trigger laminitis 
29
. Previous studies demonstrated that 
supernatant of cultures of S. bovis activates MMP-2 and is able to induce 
lamellar separation in vitro 
45
. More contradictory is the role of endotoxins in 
the pathogenesis of laminitis. In fact, while different grade endotoxemia 
accompanies the carbohydrate ingestion 
42,43
, endotoxin infusions failed to 
induce laminitis 
5,38,46
. A recent study suggested that endotoxins, once 
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absorbed through the intestine, primarily activate platelets, releasing 5-HT and 
thromboxane, two potent vasoconstrictors, and lead indirectly to the activation 
of leukocytes and the cascade of events culminating with the onset of clinical 
laminitis 
42
.  Moreover, it has been demonstrated that tryptamine, tyramine, 
phenylethylamine and other monoamines produced by decarboxylation of 
amino acids by EHSS and Lactobacilli, once released into the circulation, 
have digital vasoconstrictor effects. Though the mechanism has not 
completely been elucidated, two are hypothesized. First, these amines, 
structurally similar to 5-HT and catecholamines, may directly activate 5-HT 
receptors (tryptamine) and cause the release of norepinephrine from neuronal 
vesicles (tyramine) in the digital vessels.  Second, they may displace 




2. Black walnut extract (BWE) toxicosis: The aqueous  extract of black walnut 
(Junglas nigra) is obtained incubating 2 g black walnut shavings/kg body 
weight of in 8L of deionized water overnight at room temperature and filtering 
it. Six liters of the BWE is then administered to the horse through a 
nasogastric tube 
9,47,48
. The onset of laminitis is observed between 10-12 H 
post administration up to 90% of the animals 
47,49
. The only significant clinical 
signs observed are mild depression, increase in temperature, heart rate and 
respiratory rate starting at 4 H POA and limb edema at the time of the onset of 
laminitis. Increase of epinephrine may be secondary to stress and pain due to 
laminitis. One of the advantages is that, unlike the carbohydrate overload 
12 
 
model, the BWE model does not cause overt intestinal disturbance, 
endotoxemia or other secondary severe metabolic effects requiring the 
euthanasia of the animal 
38,47
. The most distinctive finding of this protocol is a 
30% reduction in white blood cell (WBC) count at about 3 hours post 
administration 
1,7,38,48,50
. Combined with the leukopenia, massive extravasation 
of activated leukocytes, mostly neutrophils, occurs in the perivascular regions 
of the dermal vasculature of the laminae, around skin venules 
9,10
, and in the 
hepatic and pulmonary parenchyma 
8
. Immediately after administration, the 
early peak of IL-1 and IL-8 and proinflammatory chemokines as MCP-1 and 
MCP-3, leading to the expression of E-selectin and ICAM-1, may induce 
primary endothelial activation and initiation of leukocyte extravasation 
6,10,50
. 
An intense activation of leukocytes in the prodromal stages of BWE induced 
laminitis is also confirmed by significant increases in gene expression of IL-
1, IL-6, and IL-8 in the laminar tissue and, to a lesser extent, in lungs and 
liver, and COX-2, MAIL/IkBξ
b
, G-CSF and SAA, in the laminae 
8,10,17,50-53
. 
The surprising lack of TNF-α expression in the laminae, unlike pulmonary 
and hepatic tissue, may be due to the expression of nuclear protein 
MAIL/IkBξ, which suppresses TNF-α, or due to lack of a resident monocyte 
population in the foot 
10,17
. The hypothesis that BWE administration may 
induce systemic leukocyte activation is further corroborated by recent studies 
showing an increase in concentration and activity of myeloperoxidase (MPO) 
                                                          
b
 Molecule possessing Ankyrin-repeats Induced by Lipopolysaccharide: a protein 
interacting with the transcription factor NF-k. 
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in plasma, laminar tissue and skin, concurrent with the development of 
leukopenia and the increased production of ROS, in those horses that develop 
laminitis 
48,54
. MPO is not only a marker of leukocyte activation, but a 
bioactive molecule that can generate ROS and RNS. In addition, the activation 
of cytokine receptors and toll-like receptors can induce the release of ROS 
inside the cell 
11
. Free radicals such as ROS react with proteins, DNA and 
especially lipids. The peroxidation of lipids leads to the creation of 
isoprostanes and aldehydes such as 4-hydroxy-2-nonenal (4-HNE), which are 
active molecules able to induce the oxidation of other fatty acids, activation of 
the MAPK cascade with consequential induction of COX-2 expression, 
apoptosis and interference with cytoskeleton dynamics, and may play a role in 
the dysadhesion between epidermal and dermal lamellae 
11
. Although the 
origin of BWE induced laminitis seemed to lie in the gut, the link between 
black walnut toxicosis and the mechanism initiating the laminitis is not 
completely understood. One study demonstrated that at the onset of laminitis, 
horses treated with BWE showed significant eosinophilic colitis, edema and 
hemorrhage, associated with concomitant reduction of intestinal transmucosal 
resistance in all segments of colon ex vivo 
49
.  These findings support the 
hypothesis that the intestine may be the first focus of a systemic inflammatory 
response  
1
 and that the disruption of the mucosal barrier may allow the 
release of intestinal toxins and vasoactive amines into the systemic circulation 






Calprotectin and Its Role in Inflammation 
Calprotectin belongs to the S100 proteins, a new group of molecules with an 
important role in innate immunity modulation, classified as damage associated molecular 
patterns or DAMPs. To date, more than 20 different S100 proteins have been recognized. 
They are calcium binding proteins, with two calcium binding helix-loop-helix regions 
(EF-hands) connected by a central hinge region 
55-58
. The C-terminal EF-hand is formed 
by 12 amino acids and has a higher affinity for calcium, while the N-terminal is formed 
by 14 amino acids.  In addition to binding calcium, they bind zinc in different and 
independent domains 
57,59
. Calprotectin is not an individual protein, but a combination of 
two S100 proteins: S100A8 (8 kDa, also called Calgranulin A or myeloid related protein 
8, MRP8) and S100A9 (14 kDa, also called Calgranulin B or myeloid related protein 14, 
MRP14), which are found in granulocytes, monocytes and early differentiation stages of 
macrophages. They represent 40% of cytosolic and 5% of total proteins of neutrophils 
58,60,61
. Expression of S100A8 and S100A9 is also reported in epithelial cells, 
keratinocytes and several tissues and body fluids 
55-58,60
. S100A8 and S100A9 exist in 
different isoforms and they can be found as monomers or may form active heterodimers 
or tetramers. Computer-based homology studies suggested that the residues Ile13, Tyr16, 
Phe68, Val80 and Ser86 of the S100A8 and Ile16, Phe19, Phe76, Trp88 and Met94 within the 
amino acid sequences of S100A8 and S100A9 are involved in heterodimer formation 
57
. 




Calprotectin has both intra and extra-cellular activities. As an intracellular 
calcium-binding molecule, calprotectin has signal transduction functions 
60
; it binds 
15 
 
arachidonic acid in a calcium-dependent manner, regulating its storage and mobilization 
inside the cells 
57
, and calcium-dependent S100A8/A9 tetramers promote tubulin 
polymerization and stabilization of microtubules (MTs), modulating cytoskeleton 
rearrangement during phagocyte migration 
55,56
. Upon elevation of calcium levels, the 
heterodimers are translocated to the plasma membrane, but the mechanism through which 
they penetrate and are attached to the membrane is not completely understood since both 
proteins lack a transmembrane region 
57
. Noncovalently associated S100A8/A9 
complexes are secreted by activated phagocytes and epithelial cells during inflammation. 
However, neither endosomes nor vesicles containing S100A8 or S100A9 have been 
identified in the cytosolic fraction of monocytes 
55-57
. Secretion involves two independent 
pathways. First different stimuli (cytokines, LPS…) activate protein kinase C; second, the 
contact of phagocytes with extracellular matrix protein (ECM) or activated endothelium 
elevates intracellular calcium concentration, necessary for triggering S100 protein 
release. The secretion follows an “alternative” secretory pathway, based on active 
transport via MTs and release through an unknown transmembrane transporter 
55-57
. Once 
secreted, S100A8/A9 induces activation of adhesion molecules such as vascular adhesion 
molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and various 
chemokines. Furthermore it promotes leukocyte adhesion and extravasation. It increases 
the binding capacity of integrin receptors CD11b-CD18 on the leukocyte surface to 
ICAM-1 on the endothelial cells, it induces prothrombotic and proinflammatory 
responses, and increases vascular permeability through disruption of cell junctions and 
promotion of endothelial necrosis and apoptosis 
55-57,60,61
. Calprotectin is a toll-like-
receptor endogenous activator, promoting lethal endotoxin-induced shock 
55,62
, and shows 
16 
 
zinc-dependent and independent inhibition of growth and induction of apoptosis against 
myeloid cells, mitogen-activated lymphocytes, human fibroblasts and several tumor cell 
lines in vitro 
58,63
. Calprotectin seems to have zinc-reversible antimicrobial and 
candidastatic action 
57,58,60
. Recent studies suggested that S100A8 and S100A9 proteins 
may have biological intracellular activity also as monomers. In addition, murine S100A8 
has chemotactic activity in vitro 
56-58
. Calprotectin is up-regulated in plasma and exudates 
in several diseases such as rheumatoid arthritis, Crohn‟s disease, ulcerative colitis, 
colorectal cancer, cystic fibrosis, multiple sclerosis, and HIV-infection 
56,58,60,61
. Fecal 
calprotectin is commonly used as a biomarker of intestinal inflammation 
55
. Lately, 
calprotectin has been validated for assessing neutrophil activation, adhesion and 
migration in the equine small and large intestine during experimental ischemia and 
reperfusion (I/R) 
64-66
. Previous direct and indirect methods used in both human and 
animal models, such as intravital microscopy, flow cytometry, scintigraphy, measure of 
MPO activity, histological and biochemical procedures, were cumbersome or they failed 
to localize the neutrophils within the tissue 
60,64
. Moreover, Faileros et al (2009) reported 
increased epidermal calprotectin signal at the onset of laminitis in the laminae of horses 
treated with BWE, indicating that activation of epithelial cells follows leukocyte 
migration into the laminae. This is the first evidence of induction of a proinflammatory 
molecule, which may play a role in dysadhesion between epidermal and dermal lamellae, 






Intestinal Apoptosis and Its Role in The Regulation of Barrier Function 
Cellular death occurs in two different but complimentary ways: cellular necrosis 
and apoptosis. While cellular necrosis is a passive phenomenon induced by several 
pathological factors, apoptosis is an active process that occurs in response to 
environmental or developmental cues or as a response to cell damage. Necrosis leads to 
lack of cellular homeostasis, swelling, plasma and organelle burst, and culminates in 
autodigestion and dissolution of the cell with a local inflammatory reaction 
67
. Apoptosis 
is characterized by loss of cellular contacts and cellular shrinkage, chromatin 
condensation, DNA fragmentation and cellular budding  
68-70
. Apoptosis is programmed 
by the cell with minimal tissue inflammation and plays an important role in 
embryogenesis, tissue homeostasis, lymphocyte development, and tumor regression. In 
the gastrointestinal tract, in addition to its physiological cellular turnover function, 
apoptosis has been associated with intestinal adenocarcinoma, ulcerative colitis, Crohn‟s 
disease, non-steroidal anti-inflammatory drug-related colitis, active celiac disease, burn 
shock and ischemia-reperfusion injury 
69-72
. It has also been demonstrated that horses 
with gastrointestinal simple obstruction have a significantly higher number of apoptotic 
cells in all the layers of the intestinal wall with respect to horses with musculoskeletal 
disease or controls 
68
.  
Although increased epithelial apoptosis has been associated with both small and 
large intestinal injury, the role of apoptosis in loss of the intestinal barrier function is not 
completely understood. Epithelial barrier function is controlled by trans and para-cellular 
permeability, the latter of which is restricted by tight junctions (TJ) 
72
. Although 
disruption of TJs in non-apoptotic cells may result in increased intestinal permeability, 
18 
 
studies both in vivo and in vitro showed a significant association between apoptotic rate 
and intestinal bidirectional permeability in both the small and large intestine 
70-73
. 
Moreover, Schultze et al. (2006) reported a 5% increase in apoptotic rate, associated with 
a reduction in intestinal barrier function, in mild to moderately inflamed colon specimens 
collected from patients with ulcerative colitis and Crohn‟s disease. Several cytokines, 
such as TNFα and IL-3, involved in chronic inflammatory diseases, have been reported to 
increase the apoptotic rate and colonic epithelial conductivity 
72
. The reduction of 
intestinal barrier function may allow bacteria, toxins and other molecules to reach the 
systemic circulation, resulting in septic morbidity and potentially initiating multiple 
organ dysfunction syndrome 
70,72,74
.  
As we previously described, there is a strong relationship between gastrointestinal 
disease and laminitis. Transmission electron microscopy analysis of the cecum of horses 
with CHO-induced laminitis reported progressive epithelial surface sloughing, disruption 
of microvilli, pyknotic nuclei, epithelial vacuoles and dilation of the intercellular spaces 
starting at 24 hours after starch administration 
75
. A recent study reported increased 
intestinal barrier permeability 4 hours after administration of the carbohydrate overload 
76
. Colonic impairment at the onset of laminitis has been previously described also for the 
BWE-toxicosis model 
49
. Although the author indicates a significantly decreased 
intestinal transmucosal resistance in all segments of colon, the cellular processes and 
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Tables and figures 
 
 
Figure 1.1: Hoof with its content removed (A) and magnification of the epidermal-
dermal junction (B). (A) In this hoof capsule a portion of the wall has been 
removed to show the inner structures. Notice the curve of the coronary groove 
(CG), the pigmented stratum medium of the wall and the non-pigmented 
stratum internum with the lamellae (L and arrows). (B) Primary epidermal 
lamellae (PEL) extend their surface into secondary epidermal lamellae (SEL). 
Notice the basal membrane (BM) which connects the epithelium of the 









Chapter 2: Detection of calprotectin and its correlation to apoptosis within the 
equine colon from horses with black walnut extract-induced laminitis 
 
This chapter has been formatted based on the instruction for authors in order to 
submit it to the American Journal of Veterinary Research. Some information included in 
Chapter 1 is repeated here in the introduction and discussion in order to have this 
chapter as a standalone document for subsequent submission and consideration for 
publication. 
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The objective of the present study was to investigate calprotectin expression, 
epithelial and endothelial apoptosis and their correlation in the colon of horses exposed to 
orally administered black walnut extract (BWE). Paraffin blocks of full sections of colon 
from 19 horses including 7 controls not exposed to BWE, 6 horses at the developmental 
time-point of leukopenia (DTP) and 6 at the onset of Obel grade 1 laminitis (LAM) after 
BWE-administration. Specimens were stained with H&E for histopathologic 
examination. Immunohistochemical evaluation for calprotectin expression with MAC 
387 antibody was performed along with assessment of epithelial and endothelial 
apoptosis with caspase-3 active antibody. Calprotectin expression and percentage of 
apoptotic cells were compared between controls and the two treatment groups and 
presence of a correlation between calprotectin expression and apoptosis was evaluated. 
Histological findings from BWE-treated horses included eosinophil and lymphocyte 
epitheliotropism. The DTP group had a higher (p<0.01) calprotectin score with respect to 
the control group, while there was no significant difference in percentage of epithelial 
and endothelial apoptotic cells between groups (p=0.08 and p=0.48 respectively). No 
significant correlation was found between calprotectin score and epithelial or endothelial 
apoptosis (p=0.69 and p=0.29 respectively). There is preliminary evidence that exposure 
of horses to BWE results in an early inflammatory response in the colon that may 
contribute to compromise of the intestinal barrier. Further studies are needed to 
characterize the nature of the colonic injury in BWE-exposed horses and the link to the 





Laminitis has been described as a progressive disease, in which digital pain may 
be caused by laminar inflammation or destruction, pressure either from displacement of 
the third phalanx into the sole or secondary to edema, or a combination of these.
1
  
Inflammatory laminitis is often secondary to septic disease such as gastrointestinal tract 
disorders, pleuropneumonia, retained placenta or acute metritis, endotoxemia or sepsis 
from any cause.
2,3
  Although numerous studies have been conducted  on the vascular, 
mechanical and biochemical events occurring in the equine foot during laminitis, the 
pathogenesis of this life-threatening disease is still unclear.
4
  
Due to the multifactorial origin of laminitis and the lack of consistency in its 
manifestation, understanding its pathogenesis depends mostly on reliable experimental 
models. Currently, there are two main models for inducing alimentary laminitis: CHO 
and BWE toxicosis. In contrast to the CHO model, BWE induces laminitis in up to 90% 
of horses within 12 hours post-administration without apparent intestinal disturbance, 
endotoxemia or other secondary severe metabolic effects requiring euthanasia of the 
animal.
5-7
 A consistent clinical finding is a 30%  reduction in white blood cell count 3-4 
hours post BWE administration,
1,7-10
 as is often seen in adult horses with acute 
gastrointestinal disease undergoing surgery.
a
 Combined with the leukopenia, a massive 
extravasation of activated leukocytes, mostly neutrophils, is observed in the perivascular 
regions of the dermal laminae, around skin venules,
11,12
 and in the hepatic and pulmonary 
parenchyma.
13
 This is further corroborated by demonstration of neutrophil 
myeloperoxidase in plasma, skin and laminae after BWE administration.
14
 These 
findings, along with significant increases in IL-1, IL-6 and IL-8 gene expression in 
31 
 
laminar tissue, in lungs and liver, and immunohistochemical evidence of cyclooxygenase-
2 (COX-2), molecule possessing ankyrin-repeats induced by lipopolysaccharide 
(MAIL/IkBξ), granulocyte-colony stimulating factor and serum amyloid A expression in 
the laminae,
10,12,13,15-18
 suggest that laminitis is a local manifestation of a systemic 
disease,
3,14,16,19
 comparable to multiple organ failure in human sepsis.
8,13
 Studies based on 
CHO models hypothesize that the early overgrowth of equine hindgut streptococcal 
species, followed by Lactobacillus sp. and other fermenting bacteria, decreases luminal 
pH and increases intestinal permeability, allowing the absorption of exotoxins and 
endotoxins into the systemic circulation.
20,21
 Previous studies demonstrated that 
supernatant of cultures of S. bovis activates the matrix-metalloproteinase MMP-2 and is 
able to induce lamellar separation in vitro,
22
 while endotoxins may activate platelets and 
indirectly lead to the activation of leukocytes and the cascade of events culminating with 
the onset of clinical laminitis.
23
 Other authors focus their attention on the absorption of 
vasoactive amines (such as tryptamine, tyramine and phenylethylamine) by the hindgut 




Calprotectin is a combination of two S100 proteins (the 8 kDa S100A8, also 
called Calgranulin A or myeloid related protein 8, MRP8, and the 14 kDa S100A9, also 
called Calgranulin B or myeloid related protein 14, MRP14), classified as damage 
associated molecular patterns or DAMPs, a new group of calcium binding molecules with 
an important role in innate immunity modulation. Calprotectin is found in granulocytes, 
monocytes, and early differentiation stages of macrophages and represents 40% of 
cytosolic and 5% of total proteins of neutrophils.
30-32
 Expression of calprotectin is also 
32 
 
reported in epithelial cells, keratinocytes and several tissues and body fluids.
30,31,33-35
  
Calprotectin is upregulated in plasma and exudates in several human diseases
30-32,34
 and 
today is commonly used as a fecal biomarker of intestinal inflammation.
33
 
Immunohistochemical detection of calprotectin with the  murine anti-human monoclonal 
antibody MAC387 has been validated for assessing neutrophil activation, adhesion and 
migration in the equine small and large intestine during experimental ischemia-
reperfusion.
36-38
 Faileros et al
39
 reported increased epidermal calprotectin at the onset of 
laminitis in the laminae of horses treated with BWE. Calprotectin has both intra- and 
extracellular activities, including signal transduction
30
  and modulation of cytoskeleton 
rearrangement during phagocyte migration.
33,34
 Calprotectin is a toll-like-receptor 
endogenous activator;
33,39
 it induces various chemokines, promotes leukocyte adhesion 
and extravasation, and increases vascular permeability through disruption of cell 
junctions and promotion of endothelial necrosis and apoptosis.
30,32-35
 
Apoptosis is an active process that occurs in response to environmental or 
developmental events or as a consequence of cell damage leading to cellular death with 
minimal tissue inflammation. It plays an important role in embryogenesis, tissue 
homeostasis, lymphocyte development, and tumor regression.
40
 In the gastrointestinal 
tract, in addition to its physiological cellular turnover function, apoptosis has been 
associated with intestinal adenocarcinoma, ulcerative colitis, Crohn‟s disease, non-
steroidal anti-inflammatory drug-related colitis, active celiac disease, burn shock and 
ischemia-reperfusion injury in humans.
41-44
 Studies both in vivo and in vitro showed a 
significant association between apoptotic rate and disruption of the barrier function in 
both the small and large intestine.
41-43,45
 Studies by Krueger et al.
46





describe progressive cecal mucosal damage and increased intestinal barrier permeability 
in horses after CHO administration. McConnico et al.
6
 demonstrated that at the onset of 
laminitis, horses treated with BWE showed significant eosinophilic colitis associated 
with reduction of intestinal transmucosal resistance ex vivo. These findings support the 
hypothesis that the intestine may play a significant role in the BWE-induced systemic 
inflammatory response
1
, with the disruption of the mucosal barrier may allow release of 
intestinal toxins and vasoactive amines into the systemic circulation and directly trigger 
laminitis.
4
 The cellular events leading to colonic mucosal impairment during the 
prodromic phase of BWE-induced laminitis need further investigation.   
The aim of the present study was to investigate calprotectin expression and 
apoptosis in colonic mucosa and submucosa in horses after BWE administration. Because 
of the pivotal role of leukocyte activation at the onset of laminitis,
48
 the flux and 
migration of these cells through the colonic wall was evaluated. Since calprotectin 
showed inhibition of growth and induction of apoptosis in several cell types in vitro,
31,49
 
we also wanted to investigate the correlation between calprotectin expression and the 
percentage of epithelial and endothelial apoptotic cells. We hypothesized that there would 
be an overexpression of calprotectin-positive cells and of epithelial and endothelial 
apoptosis in the colon of horses undergoing BWE administration compared with controls. 
We further hypothesized that there would be a direct correlation between calprotectin 






Materials and Methods 
Archived colon specimens from previous experiments approved by the 
Institutional Animal Care and Use Committee of The Ohio State University were used. 
Colon sections from 3 groups were used:  the DTP group (onset of leukopenia,
16
 
approximately 3–4 hours post BWE exposure; n=6), the LAM group (onset of laminitis, 
approximately 10–12 hours post BWE; n=6) and the control group (n=7). 
 
BWE-induced laminitis and sample collection  
Laminitis was induced as previously described.
11,12,39
 Briefly, BWE (Junglas 
nigra) was obtained by incubating 2 grams of black walnut shavings/kg body weight in 
8L of deionized water overnight at room temperature and filtering it. Six liters of the 
BWE or water (controls) was administered via nasogastric tube. Horses were anesthetized 
either 3-4 hours after BWE administration (DTP group), at the onset of Obel grade 1 
lameness (LAM group), or 3 to 12 hours post-water administration (control group). After 
BWE administration, horses were sedated with xylazine (1.1 mg/kg, IV) 5 minutes before 
anesthetic induction with a combination of diazepam (0.1 mg/kg) and ketamine (2.2 
mg/kg), intubated, and maintained on isoflurane. Full thickness samples of the 
antimesenteric colon were withdrawn through a standard ventral midline approach. All 
samples obtained were placed in 10% neutral buffered formalin for 24 h and then 
transferred to 70% ethanol until paraffin embedding. Each horse was euthanized with 20 
mg/kg (IV) of a solution containing pentobarbital sodium (390 mg/mL) and phenytoin 





All slices were stained with H&E for examination. Sections of colonic mucosa 
and submucosa from each specimen were examined via light microscopy by two 
investigators (E.J.E. and L.C.) using a 20x objective. Tissue samples were subjectively 
described with respect to edema, focal hemorrhage, karyorrhexis and leukocyte cell 
infiltration. All photographs were taken with a Q-fire digital camera and analyzed with 
QCapture
b
 software for Windows®. 
 
Immunohistochemistry  
Two serial 5 μm sections were deparaffinized with 100% xylene 2 times, followed 
by 50% xylene in alcohol for 3 min, and rehydrated with 100%, 95%, 70% and 50% 
ethanol in deionized water for 1 minute each. For antigen retrieval, each tissue underwent 
heat treatment in citrate buffer pH 6.0
c
 with a pressure cooker (125°C for 1 min). After 
cooling in distilled water, specimens were incubated in 0.3% hydrogen peroxide for 15 
minutes at room temperature to quench endogenous peroxidase. After rinsing with TTBS 
1 time, slides were incubated with a commercial background blocking reagent 
d
 for an 
additional 10 minutes to block nonspecific binding. Each colon section was then 
incubated with 1:100 mouse anti-human calprotectin monoclonal antibody (MAC387)
e
 
for 30 minutes at room temperature,
36,37
 or with 1:500 affinity purified rabbit polyclonal 
antibody anti human/mouse caspase 3 active
f
 overnight at 4
o
 C. The second section was 
incubated with TTBS alone as negative control. For each set of study slides subjected to 
calprotectin or caspase 3 immunohistochemistry staining, two adjacent 5 μm sections of 
normal equine lung and rat jejunum, from rats treated with 3mg/kg of lipopolysaccharide 
36 
 
intraperitoneally in a previous study, 
g
 were used as positive and negative controls, 
respectively.
36,37
 After rinsing with TTBS 3 times, the slides were incubated with a 
commercial horseradish-peroxidase conjugated anti-rabbit and anti-mouse secondary 
antibody 
h
 for 30 minutes at room temperature, and rinsed again in TTBS for 3 times. To 
demonstrate the antigen, the staining was detected with a colorimetric reaction induced 
with 3,3'-Diaminobenzidine (DAB)
i
 for 15 minutes at room temperature. Sections were 
counterstained with Mayer‟s Haematoxylin for 1 minute and, after rinsing once in 
distilled water, they were dehydrated with 50%, 70%, 95% and 100% ethanol for 1 
minute, and then passed 1 time in 50% xylene in alcohol and 2 times in 100% xylene for 
3 minutes. Sections were mounted in Cytoseal XYL mounting medium
j 
 and covered 
with glass cover slips. Tissues were observed by light microscopy using 20x 
(calprotectin) or 40x (caspase 3-active) objectives by two blinded independent 
investigators (L.C. and M.S.), and photographs were taken using 10x and 20x objectives.  
 
Calprotectin staining evaluation 
A scoring system (0–5) was used to score the distribution of positively stained 
cells: 0 indicated no neutrophils detected; 1, neutrophils limited to vasculature; 2, 
moderate to marked neutrophils showing margination within the vasculature; 3, 
marginating neutrophils in addition to perivascular neutrophils; 4, extravascular 
neutrophils and 5, severe extravascular neutrophilic infiltration in deep layers of the 





Epithelial and endothelial apoptosis evaluation 
Prior to the evaluation, two independent investigators (L.C. and M.S.) blinded to 
treatment groups agreed on a threshold for positive staining.  Only epithelial and 
endothelial cells were considered in our study and were independently evaluated. For 
epithelial cells, the number of positively stained cells in two adjacent crypts in 
longitudinal section was counted (40x objective), and the count was repeated for 10 fields 
for each slide. The percentage of positively stained cells was calculated out of the total 
number of cells counted. For endothelial cells, the percentage of positively stained cells 
was calculated out of the total number of endothelial cells identified in mucosa and 
superficial submucosa for each slide. 
 
Statistical analysis 
The data are presented as median and inter-quartile range. Significance was set at 
p<0.05. Differences in calprotectin scoring and percentage of epithelial and endothelial 
caspase-3 active positive cells between the 3 groups were evaluated using the Kruskal-
Wallis test. Post hoc pairwise multiple comparisons were performed using a Wilcoxon 
rank sum test, with Bonferroni-corrected alphas. To assess the correlation between 
calprotectin expression and apoptosis, calprotectin scores and percentage of epithelial and 
endothelial caspase 3-active positive cells were compared using Kendall‟s tau rank 










All slides showed a high percentage of eosinophils and lymphocytes in both the 
lamina propria of the mucosa and in the submucosa. Compared with tissue from control 
horses, colon specimens from the DTP group had increased eosinophil and lymphocyte 
epitheliotropism, and increased superficial lamina propria inflammatory cell karyorrhexis 
(Fig. 2.1A). Colon specimens from the LAM group showed less severe epitheliotropism 
(with predominance of lymphocytes over eosinophils) and karyorrhexis, with increased 
free neutrophils in the lamina propria of the mucosa (Fig. 2.1B). 
 
Calprotectin staining evaluation 
The staining protocol was reliable since lung control sections showed positive 
staining in alveolar macrophages and randomly distributed neutrophils with no evidence 
of spurious binding of the primary or secondary antibody (Fig. 2.2). In colonic tissue 
specimens, the cells that stained positively for calprotectin were readily differentiated 
from surrounding and adjacent cells (Fig. 2.3). The leukocytes were consistently 
intensely stained, which obscured the nuclear morphology thereby impeding 
differentiation of neutrophils from monocytes or macrophages in most cases. However, 
the distribution of positive cells closely matched the distribution of neutrophils. 
Calprotectin scores within groups are shown in Table 2.1. There was a significant 
difference in calprotectin scores between groups (p=0.04). Colon specimens from the 





Epithelial and endothelial apoptosis evaluation 
The staining protocol was reliable since rat control sections showed positive 
staining in all layers of the intestinal wall with no evidence of spurious binding of the 
primary antibody or nonspecific binding of the secondary antibody. In colonic tissue 
specimens, the cells staining positive for caspase 3-active demonstrated variability in 
intensity of the staining. However, the staining distribution was uniform along the entire 
slide. The percentages of positively stained cells in the epithelium and the endothelium 
among the groups is summarized in Table 2.1. There was no statistically significant 
difference in percentage of epithelial (Fig. 2.5) and endothelial (Fig. 2.6) apoptotic cells 
between groups (p=0.08 and p=0.48 respectively). Images of typical epithelial and 
endothelial staining among groups are shown in Fig. 2.7 and 2.8. There was no 
correlation between calprotectin score and epithelial or endothelial percentage of caspase 
3-active positive cells (p=0.69 and p=0.29 respectively). 
 
Discussion 
Insight into the effect of BWE toxicosis on equine colonic tissue was revealed in 
this study. McConnico et al. showed a significant increase in inflammation, edema, and 
hemorrhage, with increased eosinophilic infiltration and increased intestinal permeability 
ex vivo in all segments of colonic mucosa from BWE-treated horses with respect to 
controls, at the onset of Obel grade 1 laminitis.
6
 Although our histologic analysis was 
only qualitative, all colonic samples had high eosinophilic infiltration in both mucosa and 
submucosa. Specimens from the DTP group, and to a lesser degree from the LAM group, 
40 
 
showed increased eosinophil and lymphocyte epitheliotropism with respect to the control 
group in addition to inflammatory cells karyorrhexis in the superficial lamina propria. 
Our findings are in agreement with a study conducted by Rotting et al. on normal 
horses,
50
 in which eosinophils were found higher in number and closer to the mucosal 
surface in the cecum and ascending colon. The function of eosinophils under 
physiological or inflammatory conditions is not completely understood.
6,50
 They have 
been reported to increase in response to various stimuli including experimentally induced 
colitis,  ischemia-reperfusion injury, parasite infection and food allergies.
50
 In a previous 
study, an association between large intestinal eosinophilic infiltration and cyathostome 
parasitism was found.
51
 Although all horses in our study had been on deworming 
programs prior to the onset of the study, one horse had histopathologic evidence of 
parasitic larvae. However, a recent study found that the presence and distribution of 
eosinophils within different tracts of intestinal mucosa in horses is independent of S. 
vulgaris infestation.
52
 The epitheliotropism of eosinophils and lymphocytes in BWE 
treated horses may be a response to toxicosis and should be further investigated. 
Calprotectin immunohistochemical staining resulted in a reliable method for 
following neutrophilic migration through the colonic mucosa, as previously reported.
36
 
The dark staining of nuclei sometimes made it difficult to differentiate between 
neutrophils and monocytes or macrophages. Moreover, some cells were distorted during 
migration from the vessels to the lamina propria. Therefore, some of the positively 
stained cells that were identified as neutrophils may have been either infiltrated 
monocytes or activated local macrophages.  At the same time, not all the neutrophils 
stained positively for calprotectin. These neutrophils may have not been activated or may 
41 
 
have already exhausted cytoplasmic calprotectin following activation.
37
 The aim of our 
study was not to specifically identify neutrophilic infiltration, but to have an aid for 
scoring the colonic inflammatory response after BWE ingestion. Previous studies 
compared the accumulation of neutrophils counting the number of calprotectin positive 
cells per square millimeter of mucosa
38
 or dividing the mucosa into five equal zones.
36
 
Due to the multifocal-segmental aspect of the inflammation, we adopted a scoring system 
that took into account both cell quantity and degree of infiltration. Horses in the DTP 
group showed a higher calprotectin score compared with controls. These findings are in 
agreement with previous studies showing increased activated neutrophil infiltration in the 
perivascular regions of the dermal vasculature of the laminae, around skin venules,
11,12
 
and in the hepatic and pulmonary parenchyma
13
 at 3-4 hours post BWE administration. 
Although the LAM group had a higher median score than the DTP group, the difference 
was not statistically significant with respect to the control group. The small sample size, 
the high variability between horses, and the use of Bonferroni‟s adjusted alphas lowered 
the power of our estimates and with it, the ability to correctly identify a difference.  
Calprotectin was associated with zinc-dependent and independent inhibition of 
growth and induction of apoptosis in endothelial cells, myeloid cells, mitogen-activated 
lymphocytes, human fibroblasts and several tumor cell lines in vitro. 
31,32,35,49
 Studies 
both in vivo and in vitro showed a significant association between apoptotic rate and 
intestinal bidirectional permeability in both the small and large intestine.
41-43,45
 Although 
a significant correlation between calprotectin and apoptosis was not observed in this 





 This may suggest apoptosis as a component in the pathogenesis of 
experimental BWE-induced laminitis.  
There are limited studies investigating apoptosis in the horse and most are limited 
to reproductive physiology, exercise physiology and viral infection.
53
 One study 
attempting to quantify apoptosis in the gastrointestinal tract from horses with and without 
gastrointestinal disease
54
 used terminal deoxynucleotidyl transferase-mediated dUTP 
nick-end labeling (TUNEL) technique for detection of fragmented DNA associated with 
apoptosis. Although largely used, the TUNEL assay may sometimes provide spurious 
results, since necrotic cells or cells not undergoing apoptosis may result in positive 
staining.
53,55
 Immunohistochemical detection of caspase 3-active, one of the main 
components of the mitochondrial apoptotic pathway, is a valuable alternative method for 
apoptosis detection in the horse
53,56
and it was used in our study after optimization by 
variation of primary antibody incubation times and concentration.  
For assessing the role of apoptosis in the BWE model, we limited our attention to 
epithelial and endothelial cells in the mucosa and superficial submucosa. There was no 
statistically significant difference in epithelial and endothelial apoptosis between groups 
although a trend toward a higher percentage of epithelial cell apoptosis was identified in 
the DTP group compared with controls (p=0.08). Apoptosis was not correlated with 
calprotectin expression. Rowe et al. reported a high variability in intestinal apoptosis in 
horses with disease not related to the gastrointestinal tract.
54
 Calprotectin apoptotic 
effects have been reported to appear after 20 hours of exposure,
31,39
 so our samples may 
have been collected too early to detect a possible relationship between calprotectin 
expression and apoptosis.  
43 
 
BWE induced laminitis represents a reliable method for studying the link between 
gastro-intestinal disease and laminitis in the horse.
6,19
 The present study demonstrated 
that there is increased activated leukocyte infiltration in the colonic mucosa of horses 
exposed to orally administered BWE as early as 3 hours post-administration. Even 
though it is difficult to differentiate whether the colon is the first focus of the 
inflammatory reaction or if this is part of the systemic response observed with BWE-
induced laminitis, the epitheliotropism of eosinophils and lymphocytes suggests a local 
inflammatory reaction in response to BWE toxicosis.
50
 Statistically significant 
differences in epithelial and endothelial apoptosis were not identified at either time point. 
Different mechanisms, such as disruption of tight junctions in non-apoptotic cells may 
result in the increased intestinal permeability observed by other authors
6
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Table 2.1: Median calprotectin score and percentage of epithelial and endothelial 
apoptotic cells for colonic mucosa and submucosa obtained from horses treated 
with BWE at 3 hours post-treatment (DTP), at onset of Obel1 lameness (LAM) 
and controls. 
 DTP 
(median, IQ) (n) 
LAM 
(median, IQ) (n) 
Control 
(median, IQ) (n) 
Calprotectin score 3, 2-4 (6) 3.5, 1-4 (6) 1, 1-2 (7) 
Apoptosis 
epithelium 
1%, 9-12% (6) 4.5%, 2-6% (6) 4%, 3-27% (7) 
Apoptosis 
endothelium 
59.5%, 57-63% (6) 52%, 47-59% (6) 52%, 41-69% (7) 
 









Figure 2.2: Representative photomicrographs of sections of colonic mucosa obtained 
from horses treated with BWE at 3 hours post-treatment (DTP) and at the onset 
of Obel1 lameness (LAM). (A) Mucosa obtained at DTP. Notice eosinophil and 
lymphocyte epitheliotropism (arrow heads) and superficial lamina propria 
inflammatory cell karyorrhexis (arrows). (B) Mucosa obtained at LAM. Notice 
predominance of lymphocyte migration in the epithelium (arrow heads) and 






Figure 3.2: Calprotectin immunohistochemistry to detect equine alveolar 
macrophages (brown-stained cells): Negative (A) and positive controls (B) 

















































































































































































































































































































Figure 2.5: Score of calprotectin immunohistochemistry based on frequency of 
positively stained cells and migratory activity of neutrophils, for colonic 
mucosa and submucosa obtained from horses treated with BWE at 3 hours 
post-treatment (DTP), at the onset of Obel1 lameness (LAM) and controls. 
























































Figure 2.6: Percentage of epithelial apoptotic cells based on positive caspase 
3-active staining, for colonic mucosa obtained from horses treated with 
BWE at 3 hours post-treatment (DTP), at the onset of Obel1 lameness 





















































Figure 2.7: Percentage of endothelial apoptotic cells based on positive caspase 3-
active staining, for colonic mucosa and superficial submucosa obtained 
from horses treated with BWE at 3 hours post-treatment (DTP), at the 


































































































































































































































































































































































































































































































PROGNOSTIC FACTORS AFTER ESOPHAGEAL  





Chapter 3: Literature Review on Esophageal Obstruction (Choke) in Horses 
 
Esophageal obstruction or “choke” is a common clinical disorder and the most 
common esophageal condition in the horse 
1-4
. It can be a primary disorder or due to pre-




The esophagus is a musculomembranous tubular structure extending from the 
pharynx to the stomach and can be divided into proximal, thoracic and abdominal parts. 
Its wall is comprised of four layers: mucosa, submucosa, muscularis and adventitia or 
serosa (depending of the portion). The mucosa consists of stratified squamous epithelium, 
while the submucosa mostly contains elastic fibers. The muscularis mucosa of the lamina 
propria is thin in the cranial esophagus and becomes thicker approaching the cardia. The 
muscularis externa extends along the entire length of the esophagus. The orientation of 
fibers is circular toward the luminal surface and longitudinal toward the outer surface. 
The oral two-thirds of the muscular layers consists of skeletal muscle and is innervated 
by the pharyngeal and esophageal branches of the vagus nerve, while the aboral one-third 
consists of smooth muscle and is innervated by the parasympathetic fibers of the vagus 




Etiopathogenesis and Symptoms of Esophageal Obstruction 
Esophageal obstruction can occur in every portion of the esophagus, but it is more 
commonly found in the proximal portion aboral to the larynx and at the thoracic inlet 
1,3,5,6
. Esophageal obstruction can be primary or secondary 
3
. Primary obstruction is the 
most common cause of “choke” and it is usually caused by feed impaction, such as hay, 
grain, pelleted feed, beet pulp, carrots, apples or other vegetables, coarse food, corncobs 
and, more rarely, antibiotic boluses, wood or wood shavings or phytobezoar 
1,2,7-9
.  
Predisposing factors include poor dentition, inadequate water intake, eating when heavily 
sedated or during the recovery from general anesthesia 
1,3,4,10,11
. Primary esophageal 
obstructions are usually presented as isolated cases and, if promptly treated, typically do 
not recur 
11
. Esophageal obstruction can be secondary to local or systemic disorders, such 





, strictures and diverticula 
1,2,7,16,17
, esophageal motility disorders and 
neurologic and neuromuscular abnormalities. It also may occur secondary to guttural 
punch mycosis, pharyngeal trauma, botulism and grass sickness 
1,4,18-20
. A case of 




Strictures and diverticula can be primary or secondary to a previous episode of 
obstruction. Strictures have been classified into three types: Type I involves only the 
mucosa and submucosa, type II involves also the tunica muscularis and type III involves 
the entire esophageal wall. Type II and III strictures have a poor prognosis 
21
. Primary 
strictures are more common in foals. Usually they are idiopathic in nature and symptoms 
appear within the first two weeks of life 
2,18
. An unusual condition is idiopathic muscular 
62 
 
hypertrophy of the esophagus. It consists of the hypertrophy of the circular layer of the 
tunica muscularis in the distal one-third of the esophagus, and sometimes other portions 
of the gastrointestinal tract. Although it is mostly considered a coincidental finding 
during necropsy, it has been sometimes implicated in cases of recurrent esophageal 
obstruction 
22
. More common are strictures secondary to previous cases of esophageal 
obstruction or esophageal reflux, as a result of circumferential ulceration of the mucosa 
2,21,23
. Other causes of secondary stricture include trauma from a kick or from nasogastric 
tube passage and persistent right aortic arch or other vascular ring anomalies 
2,24
.  
Diverticula are differentiated as pulsion or traction diverticula. Pulsion diverticula 
are formed by herniation of the esophageal mucosa through the muscular layer due to 
increased intraluminal pressure. They form as a consequence of a kick 
2,25
 or secondary to 
esophageal stenosis/stricture.  Traction diverticula are formed by pulling forces on the 
esophageal wall due to periesophageal bands of adhesion 
1,17
.  
Symptoms of esophageal obstruction are pathognomonic and include ptyalism, 
profuse salivation, foam or alimentary discharge from the nostrils, coughing, frequent and 
ineffective attempts to swallow, retching, extension and contraction of the neck. If the 
obstruction is in the cervical part of the esophagus, a local swelling may be seen and 





Diagnosis of esophageal obstruction is usually simple based on clinical 
symptoms. The passage of a nasogastric tube allows the confirmation of an obstruction 





Determining the primary cause of an obstruction may be challenging. Especially 
in recurrent or chronic cases, the use of instrumental diagnostic tools may be required. 
Esophageal endoscopy allows direct visualization and localization of the obstruction 
1-4,7
, 
the visualization of intraluminal masses, strictures or diverticula 
4,7,18,21
 and should be 
performed on obstructions longer than 24 hours duration for assessing the integrity of the 
mucosa 
1,4
.  Motility disorders are harder to diagnose, especially if the horse is sedated. 
However they may be assessed as luminal dilation and absence of peristalsis, when the 
endoscope is pulled in a retrograde fashion from the gastric lumen 
1,15
. Before the 
esophagus, the trachea should be examined for evidence of aspiration 
7
. Endoscopy of the 
upper airways may eliminate other differential diagnoses such as guttural punch mycosis 
or neurological problems 
4,19
.  
Esophagography can give important information regarding the nature of the 
obstruction. The normal esophagus should not be visible 
1
, however in cases with 
distention proximal to an obstruction or due to peristaltic impairment, large amounts of 
intraluminal air may be detected. Air in the periesophageal region may indicate 
esophageal rupture 
1,3,4
. Plain radiography allows evaluation for the presence of 
radiopaque foreign bodies.  A more accurate evaluation of the nature of the obstruction 
can be made with contrast radiography or computed tomography (CT scan). Contrast 
radiography allows recognition of the profile of intraluminal radiolucent foreign bodies 
and outlining of diverticula or dilations. Pulsion diverticula appear rounded, with a 
narrow neck, while traction diverticula are usually smaller and have a triangular 
appearance 
1,17,25,26
. Sequential contrast radiographs allow differentiation between 
anatomical and functional strictures due to esophageal spasms 
1,18
. Using double contrast 
64 
 
enables detection of mucosal ulceration. If an irregular intraluminal or periesophageal 
mass is seen, a squamous cell carcinoma may be suspected, while a smooth regularly 
marginated appearance is more consistent with an esophageal or periesophageal abscess 
1,10,12,13,15
.  CT has been used in foals suspected of having vascular ring anomalies 
18
 and 
for evaluating the involvement of the central nervous system 
19
. In addition, 
electromyography, manometry and muscle or nerve biopsies may be required when a 
neuromuscular dysfunction is suspected 
3,18
. 
Ultrasound can be used as a complimentary aid for helping in the diagnosis of 




Nonsurgical vs. Surgical Management 
Some esophageal obstructions may resolve spontaneously, simply via withdrawal 
of access to feed and water for a few hours in combination with sedation with xylazine, 
detomidine hydrochloride, or acepromazine to improve esophageal muscle relaxation 
1,11
. 
However, many obstructions require the passage of a nasogastric tube, lavage by gravity 
or with a stomach pump and gentle pressure on the impaction to push it into the stomach 
1-4
. Sometimes removal or disruption of the impaction with endoscopic forceps is 
required 
3
. The use of mineral oil for helping the passage of the bolus is controversial 
1,4
. 
Campbell (2003) suggests using 50-100 ml of 27% lidocaine solution directly on the site 
of the obstruction, in order to relax the esophageal musculature. Oxytocin (0.11-0.22 
IU/kg) has been reported to induce transient relaxation of esophageal striated musculature 
5-15 min after IV administration in healthy horses 
5
.  However, other investigators have 





, confirming the results of an in vitro study in which oxytocin showed 
relaxation of only the esophageal smooth muscle 
6
. In a previous study, detomidine, 
acepromazine, and a combination of xylazine and butorphanol have been reported to have 
potential detrimental effects on the resolution of the esophageal obstruction because of 
the reduction in swallowing and the change in normal peristaltic activity with increases in 
high pressure events at the thoracic inlet 
27
. General anesthesia may be necessary in some 
refractory cases 
1,3
. Due to the high risk of aspiration pneumonia, all authors agree that 
many horses with esophageal obstruction should be placed on prophylactic broad-
spectrum parenteral antibiotic therapy 
1-4,7,11,18,21,28
. Non-steroidal anti-inflammatory 
drugs (NSAIDs) may help with preventing stricture formation in cases of severe 
inflammation of the esophageal mucosa 
1,2,4,21
. Feed should be withheld for 12-72 hours, 
depending on the duration of the obstruction and the grade of the mucosal lesion. The 
initial diet should be very soft and fed in small quantities several times daily 
1,4
. In cases 
of severe mucosal lesions or irresolvable choke, a nasogastric tube can be temporarily 
placed distal to the obstruction through an esophagotomy 
1
. Rarely an esophagotomy is 
required in order to resolve the obstruction 
2,3
. In a study on 61 horses, the open 
esophagotomy healed with second intention with no complications, while the sutured 
esophagotomy lead to postoperative infection and laminitis 
2
. In one study, a gastrotomy 
was used for solving an esophageal obstruction 
29
.  
Surgical intervention is more often required in case of structural modification of 
the esophagus, such as strictures or diverticula. The results of nonsurgical management of 
esophageal strictures are controversial. If modification of the diet is not strictly enforced, 
horses managed medically for esophageal strictures tend to have recurrent episodes of 
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obstruction and a poor survival rate 
23
. In a retrospective study on 61 cases of esophageal 
obstruction, surgical management of esophageal stricture had a better long term survival 
than medical management 
2
. However, studies conducted by Clabough et al. (1991) and 
Knottenbelt et al. (1992) on foals less than six months of age refuted these findings, since 
all horses had a positive response to medical management. Surgical management of 
stricture includes esophageal myectomy and esophagomyoplasty, partial resection and 
anastomosis, patch grafting of the sternocephalicus muscle, and mucosal scar fenestration 
2,26
. Two successful cases of esophagomyotomy and esophagopexy, and one case of 




Surgical management of esophageal diverticula includes diverticulectomy and 
inversion of the redundant mucosa into the esophageal lumen, followed by the repair of 
the defect in the tunica muscularis 
2,3
. Harrison and Cartee (1990) had good results 
simply by performing an esophagomyotomy extending proximally and distally to the 
diverticulum and dissecting the tunica muscularis for 180
o
 from the submucosal layer.  
 
Complications 
Complications are common and may include aspiration pneumonia, pleuritis, 
mucosal esophageal ulceration and stricture formation, esophageal perforation, chronic 




Aspiration pneumonia is the most common life threatening complication after an 
episode of esophageal obstruction 
1-3
. In a retrospective study on 34 horses with 
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esophageal obstruction, the duration of the obstruction prior to admission, but not the 
grade of tracheal contamination, was a good predictor of whether aspiration pneumonia 
would develop 
7
. The other main complication is stricture formation as a consequence of 
circumferential mucosal ulceration 
1-3,18
. Experimental stricture of the esophagus has 
been reproduced 15 days after mucosal resection and anastomosis, while naturally 
strictures may form in only a few days. For this reason, horses with a history of 
esophageal obstruction should be examined 24-48 hours after resolution for the presence 
of ulceration, and should undergo anti-inflammatory therapy to reduce the risk of 
stricture 
21
. Esophageal rupture, dehiscence, repeat stricture, mediastinitis, pleuritis, 
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Chapter 4: Retrospective review of clinical features and prognostic variables in 109 
horses with esophageal obstruction (1992-2009) 
 
This chapter has been formatted based on the instruction for authors in order to 
submit it to the Journal of Veterinary Internal Medicine. Some information included in 
Chapter 3 is repeated here in the introduction and discussion in order to have this 
chapter as a standalone document for subsequent submission and consideration for 
publication. 
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Esophageal obstruction is a commonly observed emergency in the horse and can 
result in life-threatening complications.  Previous studies have described clinical findings 
in horses with esophageal obstruction, but there are no reports that attempt to make 
correlations of clinical findings with outcome. We hypothesized that specific clinical 
features of horses with esophageal obstruction are associated with increased likelihood of 
complications. This retrospective cross-sectional study included 109 horses with 
esophageal obstruction. All clinical records of horses admitted between April 1992 and 
February 2009 for esophageal obstruction were reviewed.  The association between 24 
clinical, hematological, biochemical, therapeutic variables and the likelihood of 
complications was investigated by a univariable logistic regression model, followed by 
multivariable analysis. Multiple logistic regression analysis revealed a significant 
association between sex and age of the horse and general anesthesia with the outcome.  
Breed, heart rate, respiratory rate, whether the obstruction was in the proximal, middle or 
distal third of the esophagus, PCV, glucose, bicarbonate, anion gap, and the time elapsed 
between admission and resolution were not associated with the outcome. Intact males, 
age greater than 15 years and a need for general anesthesia were associated with 
increased likelihood of complications after an episode of esophageal obstruction.  This 
study gives insight into the understanding of other factors that may affect prognosis in 









Esophageal obstruction or “choke” is a common clinical presentation in the horse; 
most frequently it is caused by feed impaction.  Suggested causes for simple obstruction 
include ingestion of inadequately soaked sugarbeet pulp, ingestion of apples or carrots, 
excessively rapid ingestion of dry fibrous, pelleted or cubed feedstuffs, inadequate 
mastication from poor dentition, or the swallowing of a foreign body.
1,2
  Other reported 
causes include inadequate water intake, eating when heavily sedated, and esophageal 
disease including functional neuromuscular disorders, stenosis/strictures, diverticula, 
neoplasia, abscesses and cysts.
3,4
   
Horses with persistent esophageal obstruction often become compromised as a 
consequence of dehydration, acid-base and electrolyte imbalances, and aspiration 
pneumonia.
5
 Complications are common and may include esophageal mucosal ulceration, 
stricture formation, esophageal perforation, aspiration pneumonia, chronic recurrent 




There are few published studies describing the clinical findings in horses with 
esophageal obstruction and these mainly consist of smaller numbers of horses.  They also 
fail to make correlations of clinical findings with outcome.  The purpose of the present 
retrospective cross-sectional study was to describe clinical features of a population of 
horses presented to a referral institution with esophageal obstruction, and to assess the 






Material and Methods 
The clinical records of horses admitted for esophageal obstruction to the Equine 
Hospital at Colorado State University between April 1992 and February 2009 were 
analyzed.  Variables included breed, sex, age, temperature (T), heart rate (HR) and 
respiratory rate (RR) at admission, whether or not thoracic or esophageal radiographs 
were performed and radiographic findings. Radiographic evidence of alveolar or 
bronchoalveolar densities in the caudoventral region of the lungs was considered a sign 
compatible with aspiration pneumonia secondary to esophageal obstruction. When 
endoscopy was performed, tracheal contamination with food material was subjectively 
graded, as previously described,
2
 as absent, when no visible particles were detected, mild, 
when there were single food particles in the trachea, moderate, when small amounts of 
aspirated fluid were detected on the tracheal floor, or severe, when large amounts of 
aspirated fluid were detected on the tracheal floor and/or food particles were detected in 
the dorsal aspect along the trachea.  Visible esophageal lesions were classified as absence 
of irritation or swelling (normal), mild to moderate mucosal lesions, or severe lesions, 
ulcers or morphological abnormalities.  The location of the obstruction was identified as 
proximal ( 60 cm), middle (61-90 cm), or distal (> 90 cm) third of the esophagus as 
determined endoscopically, measured as centimeters from the nares, and via clinical 
examination, taking as a reference an adult Warmblood and proportionally adapting the 
measurement to smaller horses or foals.   
Hematologic and biochemical variables at the time of admission included packed 




Recorded treatments included whether antibiotics were administered and the route 
of administration (oral, parenteral or both).  Additional drug therapies documented 
included the use of non-steroidal anti-inflammatory drugs (NSAIDs), alpha-2 agonists, 
opioids, acepromazine and oxytocin.  Whether or not general anesthesia was required for 
resolving the obstruction was recorded.   
The duration of the esophageal obstruction prior to admission (less than 3 hours, 
between 3-6.3 hours, between 6.4-12.3 hours, between 12.4-48 hours or more than 48 
hours in duration) was established.  The time between admission and resolution of the 
obstruction was classified as a) relieved spontaneously by admission, b) during initial 
treatment, c) within 24 hours, d) more than 24 hours or e) never resolved. 
For the outcome variable, an animal showing any complication related directly to 
the esophageal obstruction was considered as “having complications” and these were 
specifically recorded.  
A descriptive analysis of all the recorded variables and their association with the 
outcome was undertaken.  The association between these variables and the outcome was 
assessed by logistic regression analysis.  Continuous variables were evaluated for linear 
relation with the log odds of the outcome using the Lowess smoothing function and 
whenever the assumption was not met they were categorized based upon biological 
reasoning and distribution of the population.  Variables with a univariable p0.25 were 
included into the multivariable model, which was constructed manually.  Significance 
was set at p0.05.   If a variable affected more than 20% the coefficient of another 
variable, it was considered a confounder and was forced into the model.  We checked all 










The dataset consisted of 109 records from horses admitted to the Equine Hospital 
at Colorado State University for esophageal obstruction between April 1992 and 
February 2009.  Only 5 records contained a complete collection of all variables of 
interest.  Of these 109 horses, 56 (51.4%) developed complications including aspiration 
pneumonia (39), esophageal stenosis/stricture (8), fever (4), esophageal diverticula (4) or 
rupture (2), kidney failure (2), diarrhea (2), mild esophagitis (1),  laryngeal hemiplegia 
(1), esophageal necrosis (1), laminitis (1) or a combination of these, or  the obstruction 
was not resolvable due to undetermined causes (7).  Thirteen horses (11.9%) died or were 
euthanized at the hospital as a consequence of the obstruction.  Descriptive statistics for 
variables significantly associated with the outcome as determined via univariable analysis 
are summarized in Table 4.1.  Since pneumonia alone represented almost 70% of the 
overall complications, its association with each variable of interest was further 
investigated and results are summarized in Table 4.2. 
 
Animal level variables 
The cases ranged between 2 months and 35 years of age (median 13 years) and 
included 45 Quarter Horses (41.3%), 17 Arabians (15.6%), 5 Thoroughbreds (4.6%), 8 
ponies (7.3%)  and 34 horses of other breeds (31.2%).  There were 36 females (33.1%), 





Body temperature (T) on admission ranged between 35.6C and 40.6C (median 
37.9C).  The heart rate (HR) and respiratory rate (RR) ranged between 30 -100 beats per 
minute and 8-66 breaths per minute respectively (median 56 beats/min and 24 
breaths/min respectively). Signs consistent with aspiration pneumonia were found in 25 
of the 38 horses (65.8%) that underwent thoracic radiography at admission.  
Tracheoscopy was performed on 45 horses (41.3%). Esophagoscopy was performed on 
70 horses (64.2%).  Anatomical abnormalities included eight cases of stricture.  Two 
strictures were located in the proximal one-third of the esophagus, two in the middle 
third, two in the distal third and two had an undocumented location.  Two of these were 
associated with post-stenotic diverticula, two with esophageal scars, and one with a para-
esophageal abscess in the caudal retropharyngeal region.  One half of all cases of stricture 
were foals (4/8) less than 1 year of age.  Other esophageal disorders associated with the 
esophageal obstruction ranged from moderate circumferential erosion (15) to esophageal 
ulcers (8), ranging in length from 5 cm to the entire esophagus.  Two cases of distal 
esophageal hyperplasia were diagnosed via subjective assessment at endoscopy or during 
postmortem examination.  Fifteen out of 59 obstructions (25.4%) were located in the 
middle third of the esophagus, 22 (37.3%) in the proximal and distal thirds respectively.  








Hematological and biochemical variables 
On admission, the packed cell volume (PCV) ranged between 23% and 59% 
(median 34%).  The mean total protein was 73 g/L ± 10.4 (mean±SD, range 34-99 g/L).  
Glucose measured at admission ranged between 3.3 and 16.3 mmol/L (median 7.8 
mmol/L).  Bicarbonate ranged between 13.7 and 30.6 mmol/L (median 25.6 mmol/L) and 
the anion gap between 9 and 35 mmol/L (median 15 mmol/L).   
 
Treatment-related variables 
 Of the 71 horses for which antibiotic therapy was recorded, thirteen (18.3%) 
received oral antibiotics only, 20 (28.2%) received parenteral antibiotics only, and 38 
(53.5%) received both oral and parenteral antibiotics.  Sixty-one out of 107 horses (57%), 
for which the medical therapy was recorded, were treated with NSAIDs, 87 (81.3%) 
received alpha-2-agonists and 59 (55.1%) received opioids.  All but one horse received 
opioids in association with an alpha-2 agonist.  Twenty-six (24.3%) were treated with 
acepromazine and 14 (13.1%) horses received one or more doses of oxytocin (0.11-0.22 
IU/kg IV).   
 
Other variables 
Out of 78 horses for which the duration of the choke was recorded, 11 (14.1%) 
were referred to the hospital within three hours from recognition of the choke episode, 
nine (11.5%) between 3.1 and 6.3 hours, 18 (23.1%) between 6.4 and 12.3 hours and 18 
(23.1%) within 24 hours.  Of the 22 horses (28.2%) that suffered chronic obstruction 




anatomical abnormalities endoscopically.  The majority (32/61) of obstructions were 
resolved during initial attendance.  Thirteen cases (21.3%) were not resolvable and were 
euthanized.  Since euthanasia was inevitably performed on all horses with irresolvable 
obstructive lesions, these horses were categorized as “never resolved” and removed from 
further analysis since it was lacking in statistical variability. 
 
Univariable and multivariable logistic regression analysis 
Age, presence of radiographic signs of aspiration pneumonia, grade of esophageal 
lesion as detected endoscopically, total plasma protein, type of antibiotics used, whether 
general anesthesia was required for resolution of the obstruction, and duration of the 
obstruction prior to referral had significant associations with the development of 
complications (p0.05) via univariable analyses (Table 4.1).  Breed, temperature, heart 
rate, whether the obstruction was in the proximal, middle or distal third of the esophagus, 
PCV, glucose, bicarbonate, anion gap and the time elapsed between admission and 
resolution were not associated with outcome.  Respiratory rate and grade of tracheal 
contamination, although not associated with complications as a whole, were significantly 
associated with the specific risk of developing aspiration pneumonia (Table 4.2).  Sex, 
age and whether or not general anesthesia was needed in order to solve the obstruction 
had complete observations and were thus included in the multivariable model.   
The final model was significant (p<0.01) and findings are shown in Table 4.3.  
When considering all the variables in the model, intact males were almost seven times 
more likely to develop complications than females (OR  = 6.6, 95% CI 1.4-31.6, p = 




complications than adult horses (OR= 6.2, 95%CI 2.2-17.6, p<0.01), and the requirement 
of general anesthesia for solving the obstruction increased the likelihood of developing 
complications five times (OR= 5.1, 95%CI 1.9-13.4, p<0.01).    Overall, the model fits 
the data well based on the Hosmer-Lemeshow statistic (Chi
2
 3.2, df=6, p = 0.78) and had 
a good predictive value (AUC ROC 0.79). The specificity and sensitivity of the model 
were 71.7% and 66.1% respectively.  
 
Discussion 
The short term survival rate and the complications associated with esophageal 
obstruction were in accordance with earlier findings.
6
  Previous studies reported that 
aspiration pneumonia is one of the most frequent complications after esophageal 
obstruction and a cause of mortality.
6,7
  This was confirmed by the present study, as 
aspiration pneumonia represented nearly 70% (39/56) of overall complications. Other 
complications were sporadic and often associated with pneumonia.  According to our 
study, the risk of developing aspiration pneumonia was positively associated with 
respiratory rate at admission.  Although an elevated respiratory rate can occur due to 
several reasons such as pain or stress, this could also be an indicator of early pulmonary 
impairment, as suggested by our results, in which horses with a respiratory rate greater 
than 22 breaths per min at admission were nearly six-fold more likely to develop 
aspiration pneumonia after the episode of esophageal obstruction, with respect to those 
with a rate of 12 breaths per min or less.  Feige et al.
2
 suggested that clinical and 
radiographic evaluation of the lungs is of value whenever respiratory impairment is 




of radiographic signs compatible with aspiration pneumonia and the subsequent 
development of complications.  Interestingly, radiographic signs were not directly 
associated with pneumonia.  However, this may have been a spurious finding due to the 
smaller number of horses when only aspiration pneumonia was considered as an 
outcome.  Unlike Feige et al.,
2
 we found that the extent of tracheal contamination was 
proportionally associated with the subsequent development of pneumonia (Table 4.2).   
In our study, the grade of the esophageal lesion was strongly associated with the 
subsequent development of complications.  This confirms the endoscopic exam as a 
valuable diagnostic aid for the diagnosis of mucosal impairment.  Endoscopy and contrast 
radiography of the esophagus should be strongly considered in cases of chronic or 
recurrent obstruction,
2,6-8
 as anatomic abnormalities are more likely to be present.  The 
three main anatomic abnormalities encountered were ulcers, strictures and esophageal 
diverticula.  Half of all cases of stricture were foals, in accordance with earlier findings.
6
  
The etiology of stricture in neonatal foals is not completely clear; it may be a congenital 
or developmental disorder, reflect a neurological or muscular developmental problem, or 
be the consequence of circumferential ulceration from a previous obstruction.
9-11
  While 
some of these stenoses documented in equine neonates have been reported to resolve 
after medical management, the survival rate is higher when treated surgically.
6,9
   
Unlike a previous report,
7
 we did not find any significant difference in the 
prevalence of the location of the obstruction, nor could we identify any association 
between the location and the complication rate.  
Among the hematological and biochemical variables, only total protein >70 g/L 




particular.  Perhaps this is related to either dehydration or hyperglobulinemia at 
presentation, possibly reflecting a more severe disease process.  However, due to the 
large numbers of missing observations, it is difficult to make statistical inferences on the 
clinical significance of this finding.  
Since our study population included cases collected over 17 years, the treatments 
differed widely and made it difficult to make inferences about the protocols used.  Initial 
therapy for primary esophageal obstruction is often conservative, as many will resolve 
spontaneously or with medical management consisting of sedation, smooth muscle 
relaxants, and analgesics or anti-inflammatory drugs.
1,4,12
  Tranquilization and gentle 
pressure on the obstruction with a nasogastric tube is often necessary to promote passage 
of the obstruction into the stomach.  General anesthesia may be necessary in some 
refractory cases, and surgical intervention is very rarely required.
5
  Oxytocin (0.11-0.22 
IU/kg IV) has been reported to induce transient relaxation of esophageal musculature in 
healthy horses and resolution of choke in 8 of 10 horses.
13
  However, other investigators 
have not been able to corroborate these findings using manometric evaluations of the 
esophagus in the absence of balloon distention.
14
  In a previous study, detomidine, 
acepromazine, and a combination of xylazine and butorphanol have been reported to have 
potential detrimental effects on the resolution of the esophageal obstruction because of 
the reduction in swallowing and the change in normal peristaltic activity with increases in 
high pressure events at the thoracic inlet.
14
  However, the combination of xylazine and 
butorphanol was commonly used in this population of horses.  In vitro studies suggest 
oxytocin induces relaxation of only the smooth muscle portion of the esophagus.
15




study the number of horses treated with acepromazine or oxytocin was too low and the 
number of those treated with alpha-2 agonists too high to make any statistical inferences.  
Only 13 out of 71 horses for which antibiotic therapy was recorded received oral 
antibiotics exclusively.  Horses receiving antibiotic therapy seemed to have a trend 
toward developing pneumonia (p=0.08) and those receiving both oral and parenteral 
antibiotics had a higher risk (odds) of developing complications (p=0.02).  However, this 
may have been related to the fact that those horses were considered at greater risk during 
clinical examination at admission and consequently received more aggressive and more 
prolonged antimicrobial therapy.    
Feige et al. (2000) reported that the duration of esophageal obstruction prior to 
admission was a significant risk factor for aspiration pneumonia, since the longer the 
obstruction the longer the dysphagia and thus the risk of tracheal contamination and 
aspiration of saliva and food. Unlike earlier findings, we did not find any association 
between the duration of the obstruction and the development of aspiration pneumonia; 
however, horses with a history of chronic obstruction had 9 times higher odds (OR 9.1, 
95% CI 1.7-47.7 p <0.01) of developing complications compared to horses with an 
episode of obstruction less than 3 hours in duration.  
The sex and the age of the animals, and the use of general anesthesia in order to 
resolve the obstruction were significant in the final multivariable logistic regression 
model.  Although we found that intact males were more likely to develop complications 
compared to females, their number was considerably lower than the number of females or 
castrated males, so this may represent a spurious statistical finding.  We found a strong 




of complications (specifically aspiration pneumonia) in both the univariable and 
multivariable models.  General anesthesia increases the risk of post-operative 
fatalities.
16,17
 However this association may have been affected by the fact that probably 
only the most refractory cases, already at a higher risk of complications, needed general 
anesthesia for resolution of the obstruction.  
Our findings were likely affected by changes in protocols over time and by the 
high number of variables excluded from the final model because of missing values.  The 
model is not very accurate at predicting the future onset of complications in a horse 
experiencing an episode of esophageal obstruction, because of the low sensitivity 
(66.1%) and specificity (71.7%) of the final model.  To our knowledge, this is the first 
study using a multivariable model for assessing the association between several risk 
factors and the likelihood of complications following an episode of esophageal 
obstruction.  Only sex, age and whether or not the horse underwent general anesthesia fit 
the criteria for inclusion in the multivariable model.  However, clinical variables along 
with radiographic and endoscopic results were confirmed as important tools in assessing 
the severity of the esophageal lesion and pulmonary involvement. These procedures 
should be applied in cases with recurrent esophageal obstruction because of the 
likelihood of pre-existing anatomic or functional esophageal disorders.  Two weaknesses 
in our study were the high number of missing values and the variability in procedures and 
treatments between different clinicians over the years. This is meant to be a preliminary 
study.  A prospective study including all variables of interest, including clinical variables 
along with complete radiographic and endoscopic findings and the methods used to 




not recorded in our population, may provide a real benefit to practitioners and be 
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Table 4.1: Descriptive statistics and univariable analysis of variables showing an 






N, number of horses; OR, odd ratio; CI, confidence interval; LRchi2, likelihood 
ratio chi-squared; Ref., reference value; RR, respiratory rate; X-rays AP, radiological 
signs of aspiration pneumonia; TP, total protein. 
 
Variable N. (%) N. outcomes (%) OR 95% CI LRchi2 P-value 
Sex  109  56 (51.4)   5.3 0.07 
 Female 36 (33.1) 17 (47.2) Ref. - - - 
 Gelding 56 (51.4) 26 (46.4) 1 0.4-2.2  0.90 
 Male 17 (15.6) 13 (76.5) 3.6 1-13.3  0.05 
Age (years) 109  56 (51.4)   13.5 <0.01 
 <1 17 (15.6) 12 (70.6) 5.8 1.7-20.1  <0.01 
 1-15  41 (37.6) 12 (29.3) Ref. - - - 
 >15  51 (46.8) 32 (62.7) 4.1 1.7-9.8  <0.01 
Temperature (C
o
) 91 52 (57.1)   2.9 0.23 
  37 14 (15.4) 7 (50.0) Ref. - - - 
 37.1-38 35 (38.5) 17 (48.6) 0.9 0.3-3.3  0.90 
 >38 42 (46.1) 28 (66.7) 2 0.6-6.8  0.30 
RR (bpm) 91  52 (57.1)   3.9 0.14 
 12 34 (37.4) 15 (44.1) Ref. - - - 
 13-22 25 (27.5) 17 (68.0) 2.7 0.9-7.9  0.07 
 >22 32 (35.2) 20 (62.5) 2.1 0.8-5.6  0.13 
X-rays AP 38 28 (73.7)   3.9 0.05 
 No 13 (34.2) 7 (53.8) Ref. - - - 
 Yes 25 (65.8) 21 (84.0) 4.5 1-20.7   
Tracheal contamination 45 28 (62.22)   6.9 0.07 
 None 17 (37.8) 7 (41.2) Ref. - - - 
 Mild 5 (11.1) 3 (60) 2.1 0.3-16.4  0.46 
 Moderate 18 (40) 15 (83.3) 7.1 1.4-34.4  0.01 
 Severe 5 (11.1) 3 (60) 2.1 0.3-16.4  0.46 
Grade esophageal lesion 70 40 (57.14)   12.7 <0.01 
 Absent 16 (22.9) 4 (25.0) Ref. - - - 
 Moderate 29 (41.4) 16 (55.2) 3.7 0.9-14.2  0.06 
 Severe 25 (35.7) 20 (80.0) 12 2.7-53.6  <0.01 
TP (g/L) 64  41 (64.06)   5.5 <0.01 
 70 24 (37.5) 11(45.8) Ref. - - - 
 >70 40 (62.5) 30 (75.0) 1.2 1-1.4   
Antibiotics 71 37 (52.11)   6.5 0.04 
 Oral 13 (18.3) 3 (23.1) Ref. - - - 
 Parenteral 20 (28.2) 10 (50.0) 3.3 0.7-15.8  0.13 
 Both 38 (53.5) 24 (63.2) 5.7 1.3-24.3  0.02 
General Anesthesia 109 56 (51.4)   14.6 <0.01 
 No 69 (63.3) 26 (37.7) Ref. - - - 
 Yes 40 (36.7) 30 (75.0) 5.0 2.1-11.8   
Duration (hours) 78 43 (55.13)   9.7 0.05 
 <3  11 (14.1) 3 (27.3) Ref. - - - 
 3-6.3 9 (11.5) 4 (44.4) 2.1 0.3-13.8  0.43 
 6.4-12.3 18 (23.1) 8 (44.4) 2.1 0.4-10.8  0.36 
 12.4-48 18 (23.1) 11 (61.1) 4.2 0.8-21.4  0.08 








Table 4.2:  Results of descriptive statistics and univariable analysis of variables showing 
an association (p0.05) with the likelihood of developing pneumonia after 
esophageal obstruction. 
Variable N. (%) N. outcomes (%) OR 95% CI LRchi2 P-value 
Sex  109  39 (35.8)   7.9 0.02 
 Female 36 (33.1) 9 (25.0) Ref - - - 
 Gelding 56 (51.4) 19 (33.9) 1.5 0.6-3.9  0.36 
 Male 17 (15.6) 11 (64.7) 5.5 1.6-19.2  <0.01 
Age (years) 109  39 (35.8)   8.4 0.02 
 <1 17 (15.6) 9 (23.1) 4.6 1.4-15.8  0.01 
 1-15  41 (37.6) 8 (20.5) Ref - - - 
 >15  51 (46.8) 22 (56.4) 3.1 1.2-8.1  0.02 
RR (bpm) 91  36 (39.6)   10.7 <0.01 
 12 34 (37.4) 7 (20.6) Ref - - - 
 13-22 25 (27.5) 10(40) 2.6 0.8-8.1  0.12 
 >22 32 (35.2) 19 (59.4) 5.6 1.9-16.8  <0.01 
Tracheal contamination 45 21 (46.7)   10.7 0.01 
 None 17 (37.8) 4 (23.5) Ref - - - 
 Mild 5 (11.1) 1 (20.0) 0.8 0.1-9.5  0.80 
 Moderate 18 (40) 12 (66.7) 6.5 1.5-28.8  0.01 
 Severe 5 (11.1) 4 (80.0) 13 1.1-152.3  0.04 
TP (g/L) 64  31 (48.4)   8.7 <0.01 
 70 24 (37.5) 6 (25.0) Ref - - - 
 >70 40 (62.5) 25 (62.5) 5.0 1.6-15.4   
General Anesthesia 109 39 (35.8)   10.1 <0.01 
 No 69 (63.3) 17 (24.6) Ref - - - 
 Yes 40 (36.7) 22 (55.0) 3.7 1.6-8.6  <0.01 
 
N, total number of horses; OR, odd ratio; CI, confidence interval; LRchi2, 











Table 4.3: Results of multivariable analysis for the identification of risk factors for 
complications or death after esophageal obstruction. 
 
Coeff.,  coefficient; OR, odd ratio; SE, standard error; CI,  confidence interval; 
LRchi2, likelihood ratio chi-squared; Ref., reference value.
 
Variable Coeff. OR SE 95% CI  Partial LRchi2 P-value 
Intercept -2.0 - - -  - 
Sex      6.3 0.04 
 Female Ref. - - -  - 
 Gelding 0.3 1.4 0.7 0.5-3.7  0.52 
 Males 1.9 6.6 5.3 1.4-31.6  0.02 
Age (years)     14.2 <0.01 
 1 1.4 4.0 3.0 0.9-17.6  0.07 
 1-15  Ref. - - -  - 
 >15  1.8 6.2 3.3 2.2-17.6  <0.01 
General 
Anesthesia 
1.6 5.1 2.5 1.9-13.4 12.1 <0.01 
